Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-046074
Filing Date
2024-11-14
Accepted
2024-11-14 17:22:51
Documents
70
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 933572
2 ex31-1.htm EX-31.1 18565
3 ex31-2.htm EX-31.2 18808
4 ex32-1.htm EX-32.1 8587
5 ex32-2.htm EX-32.2 8802
  Complete submission text file 0001493152-24-046074.txt   5819084

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdt-20240331.xsd EX-101.SCH 61207
7 XBRL CALCULATION FILE cdt-20240331_cal.xml EX-101.CAL 55805
8 XBRL DEFINITION FILE cdt-20240331_def.xml EX-101.DEF 232189
9 XBRL LABEL FILE cdt-20240331_lab.xml EX-101.LAB 401243
10 XBRL PRESENTATION FILE cdt-20240331_pre.xml EX-101.PRE 303218
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 891077
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-41245 | Film No.: 241464436
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)